Morgan Stanley
REPL icon

Morgan Stanley’s Replimune Group REPL Stock Holding History

Morgan Stanley’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.94M Sell
646,213
-168,675
-21% -$1.29M ﹤0.01% 4141
2025
Q4 		$7.92M Sell
814,888
-560,631
-41% -$4.77M ﹤0.01% 3809
2025
Q3 		$5.76M Buy
1,375,519
+453,861
+49% +$2.9M ﹤0.01% 4031
2025
Q2 		$8.56M Sell
921,658
-6,604
-0.7% -$57.6K ﹤0.01% 3578
2025
Q1 		$9.05M Sell
928,262
-119,365
-11% -$1.48M ﹤0.01% 3431
2024
Q4 		$12.7M Sell
1,047,627
-642,176
-38% -$7.8M ﹤0.01% 3191
2024
Q3 		$18.5M Sell
1,689,803
-45,851
-3% -$466K ﹤0.01% 2877
2024
Q2 		$15.6M Sell
1,735,654
-918,380
-35% -$6.4M ﹤0.01% 2934
2024
Q1 		$21.7M Sell
2,654,034
-6,240,422
-70% -$51.2M ﹤0.01% 2608
2023
Q4 		$75M Buy
8,894,456
+8,425,097
+1,795% +$97.7M ﹤0.01% 2019
2023
Q3 		$8.03M Sell
469,359
-184,206
-28% -$3.62M ﹤0.01% 3325
2023
Q2 		$15.2M Sell
653,565
-195,884
-23% -$3.83M ﹤0.01% 2755
2023
Q1 		$15M Buy
849,449
+235,293
+38% +$5.6M ﹤0.01% 2731
2022
Q4 		$16.7M Buy
614,156
+55,726
+10% +$1.16M ﹤0.01% 2526
2022
Q3 		$9.65M Sell
558,430
-47,389
-8% -$904K ﹤0.01% 3022
2022
Q2 		$10.6M Buy
605,819
+18,972
+3% +$312K ﹤0.01% 3015
2022
Q1 		$9.96M Buy
586,847
+235,226
+67% +$4.44M ﹤0.01% 2911
2021
Q4 		$9.53M Sell
351,621
-6,808
-2% -$204K ﹤0.01% 2999
2021
Q3 		$10.6M Sell
358,429
-36,738
-9% -$1.19M ﹤0.01% 2820
2021
Q2 		$15.2M Buy
395,167
+59,323
+18% +$2.03M ﹤0.01% 2488
2021
Q1 		$10.2M Sell
335,844
-37,622
-10% -$1.41M ﹤0.01% 2617
2020
Q4 		$14.2M Buy
373,466
+369,689
+9,788% +$15.4M ﹤0.01% 2153
2020
Q3 		$87K Sell
3,777
-37,776
-91% -$861K ﹤0.01% 5495
2020
Q2 		$1.03M Buy
41,553
+38,327
+1,188% +$678K ﹤0.01% 4145
2020
Q1 		$32K Sell
3,226
-16,470
-84% -$246K ﹤0.01% 5639
2019
Q4 		$283K Buy
19,696
+16,570
+530% +$239K ﹤0.01% 5252
2019
Q3 		$43K Sell
3,126
-17,583
-85% -$216K ﹤0.01% 5788
2019
Q2 		$304K Buy
20,709
+18,390
+793% +$266K ﹤0.01% 4841
2019
Q1 		$35K Sell
2,319
-9,404
-80% -$117K ﹤0.01% 5822
2018
Q4 		$118K Sell
11,723
-122
-1% -$1.65K ﹤0.01% 5488
2018
Q3 		$191K Buy
+11,845
New +$208K ﹤0.01% 5474

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley's REPL Position: Q1 2026 in Review

Morgan Stanley reduced its Replimune Group (REPL) stake by 21% in Q1 2026, selling an estimated $1.29M and leaving 646,213 shares worth $4.94M. The position accounts for ﹤0.01% of the portfolio, ranked #4141.

Morgan Stanley first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $75M in Q4 2023. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Morgan Stanley held 646,213 shares of Replimune Group worth $4.94M as of Q1 2026.
  • Morgan Stanley sold 168,675 Replimune Group shares in Q1 2026, an estimated $1.29M.
  • Replimune Group made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4141 holding.
  • Morgan Stanley first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Morgan Stanley's Replimune Group position peaked at $75M in Q4 2023.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.